Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Harmony Biosciences Holdings (HRMY) Other Gross PP&E Adjustments (2020 - 2025)

Harmony Biosciences Holdings (HRMY) has disclosed Other Gross PP&E Adjustments for 6 consecutive years, with -$35.3 million as the latest value for Q4 2025.

  • Quarterly Other Gross PP&E Adjustments fell 583.75% to -$35.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$35.3 million through Dec 2025, down 583.75% year-over-year, with the annual reading at -$35.3 million for FY2025, 583.75% down from the prior year.
  • Other Gross PP&E Adjustments hit -$35.3 million in Q4 2025 for Harmony Biosciences Holdings, down from -$7.2 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of -$2.3 million in Q4 2022 to a low of -$35.3 million in Q4 2025.
  • Historically, Other Gross PP&E Adjustments has averaged -$12.4 million across 5 years, with a median of -$11.2 million in 2021.
  • Biggest five-year swings in Other Gross PP&E Adjustments: increased 29.9% in 2022 and later crashed 583.75% in 2025.
  • Year by year, Other Gross PP&E Adjustments stood at -$3.3 million in 2021, then rose by 29.9% to -$2.3 million in 2022, then dropped by 1.38% to -$2.3 million in 2023, then plummeted by 120.52% to -$5.2 million in 2024, then plummeted by 583.75% to -$35.3 million in 2025.
  • Business Quant data shows Other Gross PP&E Adjustments for HRMY at -$35.3 million in Q4 2025, -$7.2 million in Q3 2025, and -$13.2 million in Q2 2025.